Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$8.59 - $18.05 $1.75 Million - $3.68 Million
-203,632 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$17.11 - $21.74 $102 - $130
-6 Reduced -0.0%
203,632 $3.85 Million
Q2 2018

Aug 14, 2018

BUY
$16.76 - $23.92 $3.41 Million - $4.87 Million
203,638 New
203,638 $3.98 Million

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $281M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Trustees Of Princeton University Portfolio

Follow Trustees Of Princeton University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Princeton University, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Princeton University with notifications on news.